CCC
TMO icon

Chesapeake Capital Corp’s Thermo Fisher Scientific TMO Stock Holding History

Chesapeake Capital Corp’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-428
Closed -$210K – 177
2026
Q1 		$210K Sell
428
-351
-45% -$190K 0.15% 152
2025
Q4 		$451K Buy
+779
New +$441K 0.38% 119

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Chesapeake Capital Corp's TMO Position: Q2 2026 in Review

Chesapeake Capital Corp sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 428 shares — an estimated $210K sold.

Chesapeake Capital Corp first reported a position in TMO in Q4 2025 and held it in 2 quarters. The position peaked at $451K in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Chesapeake Capital Corp reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Chesapeake Capital Corp sold 428 Thermo Fisher Scientific shares in Q2 2026, an estimated $210K.
  • Chesapeake Capital Corp first reported a position in Thermo Fisher Scientific in Q4 2025 and held it in 2 quarters.
  • Chesapeake Capital Corp's Thermo Fisher Scientific position peaked at $451K in Q4 2025.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Chesapeake Capital Corp's 13F filing for Q2 2026, filed 29 Jul 2026.